[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE4335454A1 - Geriatric medical composition - Google Patents

Geriatric medical composition

Info

Publication number
DE4335454A1
DE4335454A1 DE19934335454 DE4335454A DE4335454A1 DE 4335454 A1 DE4335454 A1 DE 4335454A1 DE 19934335454 DE19934335454 DE 19934335454 DE 4335454 A DE4335454 A DE 4335454A DE 4335454 A1 DE4335454 A1 DE 4335454A1
Authority
DE
Germany
Prior art keywords
vitamin
mcg
ginseng extract
composition
ginseng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19934335454
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schleicher Peter Drmed 81675 Muenchen De
Original Assignee
Schleicher Peter Drmed 81675 Muenchen De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schleicher Peter Drmed 81675 Muenchen De filed Critical Schleicher Peter Drmed 81675 Muenchen De
Priority to DE19934335454 priority Critical patent/DE4335454A1/en
Publication of DE4335454A1 publication Critical patent/DE4335454A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a geriatric medical composition in the form of a formulation containing ginseng extracts. Specifically, the composition contains, besides Siberian ginseng extract, Korean ginseng extract and L-carnitine tartrate, also a mixture of vitamins and trace elements.

Description

Die Erfindung bezieht sich auf ein neuartiges Geriatrikum und zielt darauf ab, eine Zusammensetzung bzw. ein Präparat aufzuzeigen, mit der bzw. mit dem durch optimale Auswahl und Abstimmung der einzelnen Komponenten aufeinander optimale Ergebnisse erzielbar sind, und zwar insbesondere hinsichtlich Stärkung des Immunsystems, entzündungshemmende und anti­ tumoröse Wirkungen sowie auch allgemeine Unterstützung weiterer Körperfunktionen.The invention relates to a novel Geriatrikum and aims to make a composition or a preparation show, with or by the optimal selection and Matching the individual components to each other optimal Results are achievable, in particular as regards Strengthening the immune system, anti-inflammatory and anti tumorous effects as well as general support further body functions.

Zur Lösung dieser Aufgabe wird ein Geriatrikum vorgeschlagen, welches in seiner grundlegenden Zusammensetzung folgende Elemente enthält:To solve this problem, a Geriatrikum is proposed which following in its basic composition Elements contains:

  • 1. Immunologisch wirksame Ginseng-Extrakte, nämlich sibi­ rischer Ginseng-Extrakt mit nachgewiesenen immunologischen Wirkungen und koreanischer Ginseng-Extrakt mit nachgewiesenen hor­ monellen Wirkungen;1. Immunologically effective ginseng extracts, namely sibi ginseng extract with proven immunological Effects and Korean ginseng extract with proven Hor monellen effects;
  • 2. Co-Enzym Q 10 oder andere Enzyme, über die eine hohe Effizienz entzündungshemmender Substanzen mit entgiftender und entschlackender Wirkung erreichbar ist;2. Co-enzyme Q 10 or other enzymes that have a high Efficiency of anti-inflammatory substances with detoxifying and detoxifying effect is achievable;
  • 3. ein Block aus Vitaminen und Spurenelementen, nämlich Beta-Carotin, Vitamin C, Vitamin D, Vitamin E, Vitamine B₁, B₂, B₆, B₁₂, Zink, Selen, Folsäure und Biotin, wobei diese spezielle Kombination von Vitaminen und Spuren­ elementen in Verbindung mit den anderen Bestandteilen eine hohe anti-tumoröse und immununterstützende Wirkung hat und auch andere Körperfunktionen unterstützt bzw. fördert, z. B. das Haarwachstum unterstützt und zu einer Besserung der Qualität von Haaren, Haut und Nägeln beiträgt;3. a block of vitamins and trace elements, namely Beta Carotene, Vitamin C, Vitamin D, Vitamin E, Vitamins B₁, B₂, B₆, B₁₂, zinc, selenium, folic acid and biotin, wherein this special combination of vitamins and traces elements in conjunction with the other components has high anti-tumor and immune-supporting effect and supports and promotes other bodily functions, z. B. supports hair growth and to an improvement contributes to the quality of hair, skin and nails;
  • 4. weitere Spurenelemente, z. B. Kupfer, Magnesium, Molybdän usw.4. other trace elements, eg. As copper, magnesium, molybdenum etc.

Im einzelnen weist die Verbindung beispielsweise für jeweils 200 mg Ginseng-Extrakt folgende Zusammensetzung auf:In detail, the connection, for example, for each 200 mg ginseng extract has the following composition:

Sibirischer Ginseng-Extrakt IMR-Spezial hochkonzentriert, standardisiert (aus Rhiz. Eleutherococcus sent.)|100 mgSiberian Ginseng Extract IMR Special highly concentrated, standardized (from Rhiz. Eleutherococcus sent.) | 100 mg Koreanischer Ginseng-Extrakt IMR-Spezial hochkonzentriert, standardisiert (aus Rad. Panax Ginseng)Korean Ginseng Extract IMR Special highly concentrated, standardized (from Rad. Panax Ginseng) 100 mg100 mg L-Carnitin-TartratL-carnitine tartrate 368 mg368 mg Co-Enzym Q 10Coenzyme Q 10 12 mg12 mg

sowie
Komplex aus Vitaminen, Mineralstoffen und Spurenelementen, wobei dieser Komplex für den vorgenannten Anteil an Ginseng- Extrakt vorzugsweise folgende Zusammensetzung aufweist:such as
Complex of vitamins, minerals and trace elements, this complex preferably having the following composition for the aforementioned proportion of ginseng extract:

Betacarotin (Provitamin A)|15 mgBeta carotene (provitamin A) | 15 mg Vitamin DVitamin D 300 IE300 IU Vitamin EVitamin E 50 mg50 mg Vitamin Cvitamin C 100 mg100 mg Vitamin B1Vitamin B1 1,5 mg1.5 mg Vitamin B2Vitamin B2 1,8 mg1.8 mg Vitamin B6Vitamin B6 2 mg2 mg Vitamin B12Vitamin B12 3 mcg3 mcg Nicotinamidnicotinamide 20 mg20 mg Pantothensäurepantothenic acid 10 mg10 mg Folsäurefolic acid 400 mcg400 mcg Biotinbiotin 40 mcg40 mcg Vitamin KVitamin K 30 mcg30 mcg Eiseniron 20 mg20 mg Zinkzinc 15 mg15 mg Kupfercopper 2 mg2 mg Magnesiummagnesium 30 mg30 mg Calciumcalcium 130 mg 130 mg   Phosphorphosphorus 100 mg100 mg Manganmanganese 2,5 mg2.5 mg Kaliumpotassium 15 mg15 mg Selenselenium 50 mcg50 mcg Molybdänmolybdenum 15 mcg15 mcg Chromchrome 15 mcg15 mcg

Die Verabreichungsform erfolgt in Kapseln, wobei die vor­ genannte Menge der Tagesdosis bzw. drei Kapseln entspricht.The mode of administration is in capsules, the pre corresponds to the amount of the daily dose or three capsules.

Der Anteil an Magnesium kann in gewissen Grenzen variiert werden und liegt beispielsweise in der Größenordnung zwischen etwa 30 mg und 50 mg.The proportion of magnesium can be varied within certain limits are, for example, in the order of magnitude about 30 mg and 50 mg.

100 g des Präparates enthalten dann etwa folgende Anteile:100 g of the preparation then contain approximately the following proportions:

Sibirischer Ginseng-Extrakt|5,32 gSiberian ginseng extract | 5,32 g Koreanischer Ginseng-ExtraktKorean ginseng extract 5,32 g5.32 g Co-Enzym Q10Coenzyme Q10 952,8 mg952.8 mg BetacarotinBeta carotene 794 mg794 mg Vitamin DVitamin D 575,6 mcg575.6 mcg Vitamin EVitamin E 2,7 g2.7 g Vitamin Cvitamin C 5,3 g5.3 g Vitamin B1Vitamin B1 79,4 mg79.4 mg Vitamin B2Vitamin B2 95,3 mg95.3 mg Vitamin B6Vitamin B6 111,2 mg111.2 mg Vitamin B12Vitamin B12 158,8 mcg158.8 mcg Nicotinamidnicotinamide 1,1 g1.1 g Pantothensäurepantothenic acid 539,9 mg539.9 mg Folsäurefolic acid 21,2 mg21.2 mg Biotinbiotin 2,1 mg2.1 mg Eiseniron 1,1 g1.1 g Zinkzinc 794 mg794 mg Kupfercopper 111,2 mg111.2 mg Magnesiummagnesium 2,7 g2.7 g Calciumcalcium 6,9 g6.9 g Phosphorphosphorus 5,3 g5.3 g Manganmanganese 134,9 mg 134.9 mg   Kaliumpotassium 794 mg794 mg Selenselenium 3,9 mg3.9 mg Molybdänmolybdenum 794 mcg794 mcg Chromchrome 794 mcg794 mcg

Bei einer bevorzugten Ausführungsform weist das Präparat bezogen auf jeweils 80 mg Ginseng-Extrakt folgende Zusammen­ setzung auf:In a preferred embodiment, the preparation related to each 80 mg ginseng extract following together on:

Koreanischer Ginseng-Extrakt|40,0 mgKorean Ginseng Extract | 40.0 mg Sibirischer Ginseng-ExtraktSiberian ginseng extract 40,0 mg40.0 mg Coenzym Q10Coenzyme Q10 10,0 mg10.0 mg BetacarotinBeta carotene 12 500 IE12,500 IU Vitamin D₃Vitamin D₃ 200 IE200 IU Vitamin EVitamin E 45 IE45 IU Vitamin Cvitamin C 60,0 mg60.0 mg Thiaminthiamine 0,8 mg0.8 mg Riboflavinriboflavin 1,0 mg1.0 mg Vitamin B₆Vitamin B₆ 1,0 mg1.0 mg Vitamin B₁₂Vitamin B₁₂ 1,5 mcg1.5 mcg Nicotinamidnicotinamide 10,0 mg10.0 mg Pantothensäurepantothenic acid 5,0 mg5.0 mg Folsäurefolic acid 200,0 mcg200.0 mcg Biotinbiotin 20,0 mcg20.0 mcg Eiseniron 10,0 mg10.0 mg Zinkzinc 7,5 mg7.5 mg Kupfercopper 1,0 mg1.0 mg Magnesiummagnesium 50,0 mg50.0 mg Calciumcalcium 26,0 mg26.0 mg Phosphorphosphorus 20,0 mg20.0 mg Manganmanganese 1,2 mg1.2 mg Kaliumpotassium 7,5 mg7.5 mg Selenselenium 40,0 mcg40.0 mcg Molybdänmolybdenum 7,5 mcg7.5 mcg Chromchrome 7,5 mcg7.5 mcg

Zusätzlich zu einer der vorgenannten Zusammensetzungen kann das Präparat zur weiteren Unterstützung der körpereigenen Selbstheilungskräfte auch noch natürliche Enzyme in Ver­ bindung mit Rutin enthalten, und zwar in folgender Zusammen­ setzung:In addition to one of the aforementioned compositions the preparation for further support of the body's own Self-healing powers also contain natural enzymes in Ver Contained with rutin, in the following together translation:

Pankreatin|100 mgPancreatin | 100 mg Bromelainbromelain 40 mg40 mg Papainpapain 50 mg50 mg Lipaselipase 10 mg10 mg Amylaseamylase 10 mg10 mg Trypsintrypsin 15 mg15 mg Chymotrypsinchymotrypsin 6 mg6 mg Hyaluronidasehyaluronidase 5 mg5 mg Rutinrutin 20 mg20 mg

Die Darreichungsform dieses zusätzlichen Enzym-Rutin- Komplexes sind vorzugsweise magensaftresistente Dragees, wobei die vorgenannte Aufstellung diejenige Menge enthält, die zur Herstellung von 100 Dragees ausreichend ist.The pharmaceutical form of this additional enzyme-rutin Complex are preferably enteric coated dragées, the above list containing that amount which is sufficient for the production of 100 dragees.

Durch die spezielle Auswahl der Bestandteile und deren Anteile lassen sich für das erfindungsgemäße Präparat u. a. folgende Wirkungen feststellen:Due to the special selection of components and their Shares can be u for the preparation of the invention. a. note the following effects:

Immunologische Wirkung
Hormonelle Wirkung
Entzündungshemmende und entschlackende Wirkung
Anti-tumoröse sowie vor allem auch immununterstützende Wirkung
Förderung weiterer Körperfunktionen, wie insbes. Ver­ besserung des Haarwachstums, der Qualität von Haaren, Haut und Nägeln.Immunological effect
Hormonal effect
Anti-inflammatory and detoxifying effect
Anti-tumoral and, above all, immune-supporting action
Promoting further bodily functions, in particular improving hair growth, the quality of hair, skin and nails.

Durch die verwendeten Stoffe und deren Anteile ist weiterhin durch Synergie-Effekte eine hohe Verfügbarkeit der Wirkstoffe im menschlichen Körper gewährleistet.Due to the substances used and their proportions is still through synergy effects high availability of the active ingredients guaranteed in the human body.

Claims (3)

1. Geriatrikum in Form einer Ginseng-Extrakte enthaltenen Zusammensetzung, dadurch gekennzeichnet, daß die Zusammen­ setzung auf jeweils 200 mg Ginseng-Extrakt folgende Bestandteile aufweist: Sibirischer Ginseng-Extrakt IMR-Spezial hochkonzentriert, standardisiert (aus Rhiz. Eleutherococcus sent.)|100 mg Koreanischer Ginseng-Extrakt IMR-Spezial hochkonzentriert, standardisiert (aus Rad. Panax Ginseng) 100 mg L-Carnitin-Tartrat 368 mg Co-Enzym Q 10 12 mg Betacarotin (Provitamin A) 15 mg Vitamin D 300 IE Vitamin E 50 mg Vitamin C 100 mg Vitamin B1 1,5 mg Vitamin B2 1,8 mg Vitamin B6 2 mg Vitamin B12 3 mcg Nicotinamid 20 mg Pantothensäure 10 mg Folsäure 400 mcg Biotin 40 mcg Vitamin K 30 mcg Eisen 20 mg Zink 15 mg Kupfer 2 mg Magnesium 30 mg Calcium 130 mg Phosphor 100 mg Mangan 2,5 mg Kalium 15 mg Selen 50 mcg Molybdän 15 mcg Chrom 15 mcg
1. Geriatrikum contained in the form of a ginseng extracts composition, characterized in that the composition tion on each 200 mg ginseng extract the following components: Siberian Ginseng Extract IMR Special highly concentrated, standardized (from Rhiz. Eleutherococcus sent.) | 100 mg Korean Ginseng Extract IMR Special highly concentrated, standardized (from Rad. Panax Ginseng) 100 mg L-carnitine tartrate 368 mg Coenzyme Q 10 12 mg Beta carotene (provitamin A) 15 mg Vitamin D 300 IU Vitamin E 50 mg vitamin C 100 mg Vitamin B1 1.5 mg Vitamin B2 1.8 mg Vitamin B6 2 mg Vitamin B12 3 mcg nicotinamide 20 mg pantothenic acid 10 mg folic acid 400 mcg biotin 40 mcg Vitamin K 30 mcg iron 20 mg zinc 15 mg copper 2 mg magnesium 30 mg calcium 130 mg phosphorus 100 mg manganese 2.5 mg potassium 15 mg selenium 50 mcg molybdenum 15 mcg chrome 15 mcg
2. Geriatrikum bestehend aus einer Ginseng-Extrakte auf­ weisende Zusammensetzung, dadurch gekennzeichnet, daß die Zusammensetzung auf 100 g folgende Bestandteile aufweist: Sibirischer Ginseng-Extrakt|5,32 g Koreanischer Ginseng-Extrakt 5,32 g Co-Enzym Q10 952,8 mg Betacarotin 794 mg Vitamin D 575,6 mcg Vitamin E 2,7 g Vitamin C 5,3 g Vitamin B1 79,4 mg Vitamin B2 95,3 mg Vitamin B6 111,2 mg Vitamin B12 158,8 mcg Nicotinamid 1,1 g Pantothensäure 539,9 mg Folsäure 21,2 mg Biotin 2,1 mg Eisen 1,1 g Zink 794 mg Kupfer 111,2 mg Magnesium 2,7 g Calcium 6,9 g Phosphor 5,3 g Mangan 134,9 mg Kalium 794 mg Selen 3,9 mg Molybdän 794 mcg Chrom 794 mcg
2. Geriatrikum consisting of a ginseng extracts on pointing composition, characterized in that the composition has the following components per 100 g: Siberian ginseng extract | 5,32 g Korean ginseng extract 5.32 g Coenzyme Q10 952.8 mg Beta carotene 794 mg Vitamin D 575.6 mcg Vitamin E 2.7 g vitamin C 5.3 g Vitamin B1 79.4 mg Vitamin B2 95.3 mg Vitamin B6 111.2 mg Vitamin B12 158.8 mcg nicotinamide 1.1 g pantothenic acid 539.9 mg folic acid 21.2 mg biotin 2.1 mg iron 1.1 g zinc 794 mg copper 111.2 mg magnesium 2.7 g calcium 6.9 g phosphorus 5.3 g manganese 134.9 mg potassium 794 mg selenium 3.9 mg molybdenum 794 mcg chrome 794 mcg
3. Geriatrikum bestehend aus einer Ginsing-Extrakte ent­ haltenen Zusammensetzung, dadurch gekennzeichnet, daß die Zusammensetzung auf einen Anteil von 80 mg Ginseng-Extrakt folgende Bestandteile aufweist: Koreanischer Ginseng-Extrakt|40,0 mg Sibirischer Ginseng-Extrakt 40,0 mg Coenzym Q10 10,0 mg Betacarotin 12 500 IE Vitamin D₃ 200 IE Vitamin E 45 IE Vitamin C 60,0 mg Thiamin 0,8 mg Riboflavin 1,0 mg Vitamin B₆ 1,0 mg Vitamin B₁₂ 1,5 mcg Nicotinamid 10,0 mg Pantothensäure 5,0 mg Folsäure 200,0 mcg Biotin 20,0 mcg Eisen 10,0 mg Zink 7,5 mg Kupfer 1,0 mg Magnesium 50,0 mg Calcium 26,0 mg Phosphor 20,0 mg Mangan 1,2 mg Kalium 7,5 mg Selen 40,0 mcg Molybdän 7,5 mcg Chrom 7,5 mcg
3. Geriatrikum consisting of a composition containing ginsing extracts, characterized in that the composition has the following constituents in a proportion of 80 mg ginseng extract: Korean Ginseng Extract | 40.0 mg Siberian ginseng extract 40.0 mg Coenzyme Q10 10.0 mg Beta carotene 12,500 IU Vitamin D₃ 200 IU Vitamin E 45 IU vitamin C 60.0 mg thiamine 0.8 mg riboflavin 1.0 mg Vitamin B₆ 1.0 mg Vitamin B₁₂ 1.5 mcg nicotinamide 10.0 mg pantothenic acid 5.0 mg folic acid 200.0 mcg biotin 20.0 mcg iron 10.0 mg zinc 7.5 mg copper 1.0 mg magnesium 50.0 mg calcium 26.0 mg phosphorus 20.0 mg manganese 1.2 mg potassium 7.5 mg selenium 40.0 mcg molybdenum 7.5 mcg chrome 7.5 mcg
DE19934335454 1993-10-19 1993-10-19 Geriatric medical composition Withdrawn DE4335454A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19934335454 DE4335454A1 (en) 1993-10-19 1993-10-19 Geriatric medical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934335454 DE4335454A1 (en) 1993-10-19 1993-10-19 Geriatric medical composition

Publications (1)

Publication Number Publication Date
DE4335454A1 true DE4335454A1 (en) 1995-04-20

Family

ID=6500409

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19934335454 Withdrawn DE4335454A1 (en) 1993-10-19 1993-10-19 Geriatric medical composition

Country Status (1)

Country Link
DE (1) DE4335454A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
EP0787489A2 (en) * 1995-12-15 1997-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid
EP0797993A1 (en) * 1996-03-29 1997-10-01 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Compostions comprising l-carnitine or derivatives thereof and antioxidants
WO1998034610A1 (en) * 1997-02-10 1998-08-13 Groton Robert B Composition for improving hair regrowth and method of use
FR2760358A1 (en) * 1997-03-04 1998-09-11 Francois Ballester Cosmetic revitalising composition for combatting whitening of hair with age
FR2773484A1 (en) * 1998-01-09 1999-07-16 Pierre Moreau Micronutritional compositions having a therapeutic effect containing polyunsaturated fatty acids, trace elements, and vitamins
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
WO2001051051A2 (en) * 2000-01-11 2001-07-19 Avikam Harel AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS
FR2819401A1 (en) * 2001-01-16 2002-07-19 Oreal Composition for improving the quality and appearance of nails includes mixture of vitamins and mineral salts
JP2004155778A (en) * 2002-10-16 2004-06-03 Taisho Pharmaceut Co Ltd Nutritional supplement containing ubiquinone
WO2005039320A2 (en) * 2003-10-01 2005-05-06 Boehringer Ingelheim International Gmbh Composition for the activation of the immune system
EP1539100A2 (en) * 2002-07-11 2005-06-15 Dermipsor Ltd Composition and methods for the treatment of skin disorders
EP1570751A1 (en) * 2004-03-02 2005-09-07 Boehringer Ingelheim International GmbH Composition for the activation of the immune system
EP2269649A3 (en) * 2004-08-26 2011-08-10 Merz Pharma GmbH & Co. KGaA Compositions containing a capillary active system with application-related differentiability, and the use thereof
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405581A1 (en) * 1983-02-16 1984-10-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Rom/Roma PHARMACEUTICAL COMPOSITION WITH METABOLIC AND ENERGY EFFECTIVENESS FOR USE IN HEART AND VESSEL THERAPY
CH661443A5 (en) * 1984-11-22 1987-07-31 Seuref Ag Pharmaceutical compositions having metabolic activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405581A1 (en) * 1983-02-16 1984-10-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Rom/Roma PHARMACEUTICAL COMPOSITION WITH METABOLIC AND ENERGY EFFECTIVENESS FOR USE IN HEART AND VESSEL THERAPY
CH661443A5 (en) * 1984-11-22 1987-07-31 Seuref Ag Pharmaceutical compositions having metabolic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Rote Liste 1993, Arzneimittelverzeichis des BPI, Editio Cantor, Aulendorf/Württ., Nr.42005, Geriatric Pharmaton *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718898B2 (en) * 1995-09-05 2000-04-20 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Anti-stress agents for aquatic animals
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
US6306453B1 (en) 1995-09-05 2001-10-23 Warner-Lambert Company Anti-stress agents for aquatic animals
EP0787489A2 (en) * 1995-12-15 1997-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid
EP0787489A3 (en) * 1995-12-15 1997-09-10 Sigma Tau Ind Farmaceuti
EP0797993A1 (en) * 1996-03-29 1997-10-01 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Compostions comprising l-carnitine or derivatives thereof and antioxidants
WO1998034610A1 (en) * 1997-02-10 1998-08-13 Groton Robert B Composition for improving hair regrowth and method of use
FR2760358A1 (en) * 1997-03-04 1998-09-11 Francois Ballester Cosmetic revitalising composition for combatting whitening of hair with age
FR2773484A1 (en) * 1998-01-09 1999-07-16 Pierre Moreau Micronutritional compositions having a therapeutic effect containing polyunsaturated fatty acids, trace elements, and vitamins
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
AU750645B2 (en) * 1998-04-17 2002-07-25 Sigma-Tau Healthscience S.P.A. Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
WO2001051051A2 (en) * 2000-01-11 2001-07-19 Avikam Harel AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS
WO2001051051A3 (en) * 2000-01-11 2002-06-27 Avikam Harel Agents, such as nicotinamide or cadpr for the treatment of skin disorders
FR2819401A1 (en) * 2001-01-16 2002-07-19 Oreal Composition for improving the quality and appearance of nails includes mixture of vitamins and mineral salts
EP1539100A2 (en) * 2002-07-11 2005-06-15 Dermipsor Ltd Composition and methods for the treatment of skin disorders
EP1539100A4 (en) * 2002-07-11 2006-01-18 Dermipsor Ltd Composition and methods for the treatment of skin disorders
JP2004155778A (en) * 2002-10-16 2004-06-03 Taisho Pharmaceut Co Ltd Nutritional supplement containing ubiquinone
WO2005039320A2 (en) * 2003-10-01 2005-05-06 Boehringer Ingelheim International Gmbh Composition for the activation of the immune system
WO2005039320A3 (en) * 2003-10-01 2005-07-14 Boehringer Ingelheim Int Composition for the activation of the immune system
JP2007507441A (en) * 2003-10-01 2007-03-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immune system activation composition
EP1570751A1 (en) * 2004-03-02 2005-09-07 Boehringer Ingelheim International GmbH Composition for the activation of the immune system
EP2269649A3 (en) * 2004-08-26 2011-08-10 Merz Pharma GmbH & Co. KGaA Compositions containing a capillary active system with application-related differentiability, and the use thereof
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US9603861B2 (en) 2005-05-10 2017-03-28 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases

Similar Documents

Publication Publication Date Title
DE4335454A1 (en) Geriatric medical composition
DE69803099T2 (en) COMPOSITION FOR THE TREATMENT OF SMELLING BREATH
EP0874618B1 (en) Preparation for improving hair growth, the skin structure and/or nail regeneration
EP0435913B1 (en) Effervescent tablet
DE19831798A1 (en) Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
EP0209724B1 (en) Preparation effective against acne and the use of an active extract of couch grass
DE69400353T2 (en) Slimming composition
DE60126535T2 (en) Use of a composition with vitamins and inorganic salts to reduce hair loss and / or to promote regrowth of the hair
HUT75650A (en) Use of flupirtine to prepare pharmaceutical compositions suitable for the treatment of neurodegenerative diseases
EP0037488A2 (en) Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes
EP0008052B1 (en) Anti-inflammatory and blood-stanching medicament
DE102007034957B4 (en) Cosmetic procedure for influencing the skin
EP1242105B1 (en) Combination of ginseng and ginkgo to improve cognitive skills
DE3820218C2 (en)
DE19608563A1 (en) Preparation for oral delivery of pharmaceutical or nourishing materials
EP2106705B1 (en) Use of a compound comprising a vegetable lectin, a proteolytic enzyme and a selenium compound for mucous membrane protection and relief of other symptoms experienced by cancer patients
US20080267899A1 (en) Plant extract composition for hair growth
HU203668B (en) Cosmetic containing medicinal plants and process for producing composition against psoriasis
Cheney Aloe drug in human therapy
EP0497800B1 (en) Composition for hair growth stimulation
DE3728367C1 (en) Means for immunizing the human body against HIV infections
DE10204637A1 (en) Pharmaceutical, nutritional or food additive composition containing gamma-linolenic acid, isoflavone and lignan, is effective e.g. against tumors, osteoporosis and premenstrual syndrome
EG17992A (en) Preparation of a medicament for arthritis and theumatism
DE19633446B4 (en) Medicinal products with lipid-lowering action
US5968518A (en) Composition and method for treating premenstrual syndrome

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee